Latest filing published 24 Apr 2026 for Telomir Pharmaceuticals, Inc., €8.6M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Erez Aminov: trading record in brief
This profile gathers the share dealings of Erez Aminov across 2 companies, led by Mira Pharmaceuticals, Inc. and Telomir Pharmaceuticals, Inc. The record holds 13 filings, for trades running from 21 May 2024 to 22 April 2026.
Both buying and selling appear: 8 purchases worth €7,532, against 2 sales worth €126k. Netting one side against the other leaves €119k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
A typical purchase (the median) is worth €764. None of the 8 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 24 April 2026 came the latest disclosure, a transaction for €8.6M in Telomir Pharmaceuticals, Inc. The last insider purchase was made public on 22 May 2024, 900 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Erez Aminov
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,319,710 shares@ US$1.3711.46% mcap100.0% of flowCommon StockSEC:0001493152-26-018911:0
- 2,685,456 sharesCommon StockSEC:0001493152-25-016957:0
- 62,500 shares@ US$1.3749.6% of flowCommon StockSEC:0001641172-25-026388:0
- 55,410 shares@ US$1.3949.2% of flowCommon StockSEC:0001493152-24-047998:0
- 2,000 shares@ US$1.001.2% of flowCommon StockSEC:0001493152-24-021069:0Canonical exit: 19 Aug 2024 (T+90)
5 of 5 declarations